Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Genetically engineered rat models for breast cancer.

Smits BM, Cotroneo MS, Haag JD, Gould MN.

Breast Dis. 2007;28:53-61. Review.

PMID:
18057543
2.

Special considerations in mouse models of breast cancer.

Borowsky A.

Breast Dis. 2007;28:29-38. Review. No abstract available.

PMID:
18057541
3.
4.

Genetically engineered rodent models of mammary gland carcinogenesis: an overview.

Blackshear PE.

Toxicol Pathol. 2001 Jan-Feb;29(1):105-16. Review.

5.

Recent developments in critical genes in the molecular biology of breast cancer.

Sunpaweravong S, Sunpaweravong P.

Asian J Surg. 2005 Jan;28(1):71-5. Review.

6.

Recent advances in breast cancer biology.

Schultz LB, Weber BL.

Curr Opin Oncol. 1999 Nov;11(6):429-34. Review.

PMID:
10550005
7.

Signal transduction in transgenic mouse models of human breast cancer--implications for human breast cancer.

Marcotte R, Muller WJ.

J Mammary Gland Biol Neoplasia. 2008 Sep;13(3):323-35. doi: 10.1007/s10911-008-9087-3. Epub 2008 Jul 24. Review.

PMID:
18651209
8.

Progestins and breast cancer.

Aupperlee M, Kariagina A, Osuch J, Haslam SZ.

Breast Dis. 2005-2006;24:37-57. Review.

PMID:
16917138
9.

The role of ras gene expression and transforming growth factor alpha production in the etiology and progression of rodent and human breast cancer.

Salomon DS, Ciardiello F, Valverius EM, Kim N.

Cancer Treat Res. 1991;53:107-57. Review. No abstract available.

PMID:
1672074
10.

Preclinical mouse models for BRCA1-associated breast cancer.

Drost RM, Jonkers J.

Br J Cancer. 2009 Nov 17;101(10):1651-7. doi: 10.1038/sj.bjc.6605350. Epub 2009 Sep 29. Review.

11.

BRCA1 deficient mouse models to study pathogenesis and therapy of triple negative breast cancer.

Diaz-Cruz ES, Cabrera MC, Nakles R, Rutstein BH, Furth PA.

Breast Dis. 2010;32(1-2):85-97. doi: 10.3233/BD-2010-0308. Review.

12.

Chromosome alterations in rat mammary tumor progression.

Aldaz CM, Gollahon LS, Chen A.

Prog Clin Biol Res. 1992;376:137-53. Review. No abstract available.

PMID:
1528918
13.

The reciprocal dance between cancer and development.

Chodosh LA.

N Engl J Med. 2002 Jul 11;347(2):134-6. Review. No abstract available.

PMID:
12110743
14.

Modeling metastatic breast cancer in mice.

Jonkers J, Derksen PW.

J Mammary Gland Biol Neoplasia. 2007 Sep;12(2-3):191-203. Review.

PMID:
17587153
15.

Can genetic testing guide treatment in breast cancer?

Tutt A, Ashworth A.

Eur J Cancer. 2008 Dec;44(18):2774-80. doi: 10.1016/j.ejca.2008.10.009. Epub 2008 Nov 20. Review.

PMID:
19027287
16.

Triple negative tumours: a critical review.

Reis-Filho JS, Tutt AN.

Histopathology. 2008 Jan;52(1):108-18. doi: 10.1111/j.1365-2559.2007.02889.x. Review.

PMID:
18171422
17.

The promise of genetically engineered mice for cancer prevention studies.

Green JE, Hudson T.

Nat Rev Cancer. 2005 Mar;5(3):184-98. Review.

PMID:
15738982
18.

Update on genetic predisposition to breast cancer.

Ahmed M, Lalloo F, Evans DG.

Expert Rev Anticancer Ther. 2009 Aug;9(8):1103-13. doi: 10.1586/era.09.38. Review.

PMID:
19671030
20.

Therapeutic options for triple-negative breast cancers with defective homologous recombination.

Jaspers JE, Rottenberg S, Jonkers J.

Biochim Biophys Acta. 2009 Dec;1796(2):266-80. doi: 10.1016/j.bbcan.2009.07.001. Epub 2009 Jul 17. Review.

PMID:
19616605
Items per page

Supplemental Content

Write to the Help Desk